Propofol inhibits invasion and enhances paclitaxelinduced apoptosis in ovarian cancer cells through the suppression of the transcription factor slug

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 13, 2013, Pages 1722-1729

  Wang, P ^a   Chen, J ^b   Mu, L H ^a   Du, Q H ^a   Niu, X H ^a   Zhang, M Y ^a  

^a SHANDONG UNIVERSITY   (China)

^b People's Hospital of Huai Yin District   (China)

Author keywords

Chemotherapy; Metastasis; Ovarian cancer; Transcription factor

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; PACLITAXEL; PROPOFOL; TRANSCRIPTION FACTOR SLUG; ANTINEOPLASTIC AGENT; INTRAVENOUS ANESTHETIC AGENT; SNAIL FAMILY TRANSCRIPTION FACTORS; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; BOYDEN CHAMBER ASSAY; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHEMOSENSITIVITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; NICK END LABELING; OVARY CANCER; PROCEDURES; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; TUMOR INVASION; WESTERN BLOTTING; DRUG RESISTANCE; FEMALE; GENETICS; OVARY TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANESTHETICS, INTRAVENOUS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; FEMALE; HUMANS; IN SITU NICK-END LABELING; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; PACLITAXEL; PROPOFOL; TETRAZOLIUM SALTS; THIAZOLES; TRANSCRIPTION FACTORS;

EID: 84884187979     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. SCHUMMER M, PALEY PJ, THOMPSON L, STEWART J, FORD M, CRAWFORD M. Analysis of ovarian tumor antigens reveals a bias antigens encoded on 17q. Int J Cancer 2003; 184: 73-84.
2. YAP TA, CARDEN CP, KAYE SB. Beyond chemotherapy: targeted therapies in ovarian cancer. Nature Rev Cancer 2009; 9: 167-181.
3. GOFF BA, SAINZ DE LA CUESTA R, MUNTZ HG, FLEISCHHACKER D, EK M, RICE LW. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol 1996; 60: 412-417.
4. MILLER M, OJIMA I. Chemistry and Chemical biology of taxan anticancer agents. The Chem Record 2001; 1: 195-211.
5. TANG P, YU Z, ZHANG K, WANG Y, MA Z, ZHANG S, CHEN D, ZHOU Y. Slug down-regulation by RNA interference inhibits invasion growth in human esophageal squamous cell carcinoma. BMC Gastroenterol 2011; 11: 60.
6. WANG X, ZHANG K, SUN L, LIU J, LU H. Short interfering RNA directed against Slug blocks tumor growth, metastasis formation, and vascular leakage in bladder cancer. Med Oncol 2011; 28(Suppl) S413-422
7. ZHANG K, CHEN D, JIAO X, ZHANG S, LIU X, CAO J, WU L, WANG D. Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling. Lab Invest 2011; 91: 426-438.
8. KURREY NK, K A, BAPAT SA. Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level. Gynecol Oncol 2005; 97: 155-165.
9. ZHANG K, CHEN D,WANG X, ZHANG S,WANG J, GAOY, YAN B. rna interference targeting slug increases cholangiocarcinoma cell sensitivity to cisplatin via upregulating PUMA. Int J Mol Sci 2011; 12: 385-400.
10. ZHANG K, ZHANG B, LU Y, SUN C, ZHAO W, JIAO X, HU J, MU P, LU H, ZHOU C. Slug inhibition upregulates radiation-induced PUMA activity leading to apoptosis in cholangiocarcinomas. Med Oncol 2011; 28(Suppl 1: S301-309.
11. KURREY NK, JALGAONKAR SP, JOGLEKAR AV, GHANATE AD, CHASKAR PD, DOIPHODE RY, BAPAT SA. Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells 2009; 27: 2059-2068.
12. BANI MR, NICOLETTI MI, ALKHAROUF NW, GHILARDI C, PETERSEN D, ERBA E, SAUSVILLE EA, LIU ET, GIAVAZZI R. Gene expression correlating with response to paclitaxel in ovar ian carcinoma xenografts. Mol Cancer Ther 2004; 3: 111-121.
13. MARIK PE. Propofol: therapeutic indications and sideeffects. Curr Pharm Des 2004; 10: 3639-3649.
14. VASILEIOU I, XANTHOS T, KOUDOUNA E, PERREA D, KLONARIS C, KATSARGYRIS A, PAPADIMITRIOU L. Propofol: a review of its non-anaesthetic effects. Eur J Pharmacol 2009; 605: 1-8.
15. WU KC, YANG ST, HSIA TC, YANG JS, CHIOU SM, LU CC, WU RS, CHUNG JG. Suppression of cell invasion and migration by propofol are involved in down-regulating matrix metalloproteinase-2 and p38 MAPK signaling in A549 human lung adenocarcinoma epithelial cells.Anticancer Res 2012; 32: 4833-4842.
16. MAMMOTO T, MUKAI M, MAMMOTO A, YAMANAKA Y, HAYASHI Y, MASHIMO T, KISHI Y, NAKAMURA H. Intravenous anesthetic, propofol inhibits invasion of cancer cells. Cancer Lett 2002; 184: 165-170.
17. MIAO Y, ZHANG Y, WAN H, CHEN L, WANG F. GABAreceptor agonist, propofol inhibits invasion of colon carcinoma cells. Biomed Pharmacother 2010; 64: 583-588.
18. ZHANG L, WANG N, ZHOU S, YE W, JING G, ZHANG M. Propofol induces proliferation and invasion of gallbladder cancer cells through activation of Nrf2. J Exp Clin Cancer Res 2012; 31: 66.
19. DU Q, XU Y, ZHANG M, YUN P, HE C. Propofol induces apoptosis and increases gemcitabine sensitivity in pancreatic cancer cells in vitro by inhibition of NF-B activity. World J Gastroenterol 2013 May (In press).
20. KUSHIDA A, INADA T, SHINGU K. Enhancement of antitumor immunity after propofol treatment in mice. Immunopharmacol Immunotoxicol 2007; 29: 477-486.
21. SÁNCHEZ-GARCÍA I. The crossroads of oncogenesis and metastasis. N Engl J Med 2009; 360: 297-299.
22. UCHIKADO Y, NATSUGOE S, OKUMURA H, SETOYAMA T, MATSUMOTO M, ISHIGAMI S, AIKOU T. Slug increases sensitivity to tubulin-binding agents via the downregulation of III and IVa-tubulin in lung cancer cells. Clin Cancer Res 2005; 11: 1174-1180.
23. KATAFIASZ D, SMITH LM, WAHL JK 3RD. Slug (SNAI2) expression in oral SCC cells results in altered cell-cell adhesion and increased motility.Cell Adh Migr 2011; 5: 315-322.
24. YANG HW, MENON LG, BLACK PM, CARROLL RS, JOHNSON MD. SNAI2/Slug promotes growth and invasion in human gliomas.BMC Cancer 2010; 10: 301.
25. ZHANG K, ZHANG S, JIAO X, WANG H, ZHANG D, NIU Z, SHEN Y, LV L, ZHOU Y. Slug regulates proliferation and invasiveness of esophageal adenocarcinoma cells in vitro and in vivo. Med Oncol 2011; 28: 1089-1100.
26. JOSEPH MJ, DANGI-GARIMELLA S, SHIELDS MA, DIAMOND ME, SUN L, KOBLINSKI JE, MUNSHI HG. Slug is a downstream mediator of transforming growth factor-beta1-induced matrix metalloproteinase-9 expression and invasion of oral cancer cells. J Cell Biochem 2009; 108: 726-736.
27. HASLEHURST AM, KOTI M, DHARSEE M, NUIN P, EVANS K, GERACI J, CHILDS T, CHEN J, LI J, WEBERPALS J, DAVEY S, SQUIRE J, PARK PC, FEILOTTER H. EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. BMC Cancer 2012; 12: 91.
28. JIA J, ZHANG W, LIU JY, CHEN G, LIU H, ZHONG HY, LIU B, CAI Y, ZHANG JL, ZHAO YF. Epithelial mesenchymal transition is required for acquisition of anoikis resistance and metastatic potential in adenoid cystic carcinoma. PLoS One 2012; 7: e51549.
29. PETERS CE, KORCOK J, GELB AW, WILSON JX. Anesthetic concentrations of propofol protect against oxidative stress in primary astrocyte cultures: comparison with hypothermia. Anesthesiology 2001; 94: 313-321.
30. VELLY LJ, GUILLET BA, MASMEJEAN FM, NIEOULLON AL, BRUDER NJ. Neuroprotective effects of propofol in a model of ischemic cortical cell cultures: role of glutamate and its transporters. Anesthesiology 2003; 99: 368-375.
31. QI S, ZHAN RZ, WU C, FUJIHARA H, TAGA K. The effects of thiopental and propofol on cell swelling induced by oxygen/glucose deprivation in the CA1 pyramidal cell layer of rat hippocampal slices. Anesth Analg 2002; 94: 655-660.
32. ZHOU QL, YANG CX, LIANG H, LIU HZ, WANG HB, LIU Y, LAI XH, GU MN. Propofol reduces MMPs expression by inhibiting PI3K/AKT activity in human HepG2 cells. Biomed Pharmacother 2013, pii: S0753-3322(13)00008-5.